Table 6 Descriptions of potential prescribing omissions as per START criteria (n = 57)

Cardiovascular System

B05. Angiotensin Converting Enzyme (ACE) inhibitor for heart failure with reduced ejection fraction

1

1.8

B06. Cardio-selective beta-blocker (bisoprolol, nebivolol, metoprolol or carvedilol) for stable heart failure with reduced ejection fraction

14

24.6

B07. Mineralocorticoid receptor antagonist (spironolactone, eplerenone) in heart failure without severe renal function impairment i.e., eGFR > 30 ml/min/m²

1

1.8

Gastrointestinal System

F03. Proton Pump Inhibitors (PPIs) with short-term (< 2 weeks) or longer-term (> 2 weeks) NSAID

41

71.9